A comparative study of erectile function and use of erectile aids in high-risk prostate cancer patients after robot-assisted laparoscopic prostatectomy

References

• D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969–74.
   PubMed Web of Science ®Google Scholar
• Albertsen PC, Hanley JA, Fine J. 20-years outcomes following conservative management of clinically localized prostate cancer. JAMA 2005;293:2095–101.
   PubMed Web of Science ®Google Scholar
• Joniau S, Tosco L, Briganti A, Vanden Broeck T, Gontero P, Karnes RJ, et al. Results of surgery for high-risk prostate cancer. Curr Opin Urol 2013;23:342–8.
   PubMed Web of Science ®Google Scholar
• Petrelli F, Vavassori I, Coinu A, Borgonovo K, Sarti E, Barni S. Radical prostatectomy or radiotherapy in high-risk prostate cancer: a systematic review and metaanalysis. Clin Genitourol Cancer 2014;12:215–24.
   PubMed Web of Science ®Google Scholar
• Fu Q, Moul JW, Sun L. Contemporary radical prostatectomy. Prostate Cancer 2011;2011:645030.
   Google Scholar
• Silberstein JL, Vockers AJ, Power NE, Fine SW, Scardino PT, Eastham JA, et al. Reverse stage shift at a tertiary care center. Escalating risk in men undergoing radical prostatectomy. Cancer 2011;117:4855–60.
   PubMed Web of Science ®Google Scholar
• Ghavamian R, Williams SK, Hakimi AA. High-risk prostate cancer: the role of radical prostatectomy for local therapy. Future Oncol 2011;7:543–50.
   PubMed Web of Science ®Google Scholar
• Ingels A, de la Taille A, Ploussard G. Radical prostatectomy as primary treatment of high-risk prostate cancer. Curr Urol Rep 2012;13:179–86.
   PubMedGoogle Scholar
• Matthew AG, Goldman A, Trachtenberg J, Robinson J, Horsburgh S, Currie K, et al. Sexual dysfunction after prostatectomy: prevalence, treatments, restricted use of treatments and distress. J Urol 2005;74:2105–10.
   Web of Science ®Google Scholar
• Mulhall JP. Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions. J Urol 2009;181:462–71.
   PubMed Web of Science ®Google Scholar
• Ficarra V, Novara G, Ahlering TE, Costello A, Eastham JA, Graefen M, et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 2012;62:418–30.
   PubMed Web of Science ®Google Scholar
• Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, et al. Prediction of erectile function following treatment for prostate cancer. JAMA 2011;306:1205–14.
   PubMed Web of Science ®Google Scholar
• Ou YC, Yang CK, Wang J, Hung SW, Cheng CL, Tewari AK, et al. The trifecta outcome in 300 consecutive cases of robotic-assisted laparoscopic radical prostatectomy according to D’Amico risk criteria. Eur J Surg Oncol 2013;39:107–13.
   PubMed Web of Science ®Google Scholar
• Bergman J, Gore JL, Penson DF, Kwan L, Litwin MS. Erectile aid use in men treated for localized prostate cancer. J Urol 2009;182:649–54.
   PubMed Web of Science ®Google Scholar
• Miller DC, Wei JT, Dunn RL, Montie JE, Pimentel H, Andler HM, et al. Use of medication or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference. Urology 2006;68:166–71.
   PubMed Web of Science ®Google Scholar
• Plym A, Folkvaljon Y, Garmo H, Holmberg L, Johansson E, Fransson P, et al. Drug prescription for erectile dysfunction before and after diagnosis of localized prostate cancer. J Sex Med 2014;11:2100–8.
   PubMed Web of Science ®Google Scholar
• Szymanski KM, Wei JT, Dunn RL, Sanda MG. Development and validation of an abbreviated version of the Expanded Prostate Cancer Index Composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology 2010;76:1245–50.
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey – construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.
   PubMed Web of Science ®Google Scholar
• Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1171–8.
   PubMed Web of Science ®Google Scholar
• Bjelland I, Dahl AA, Tangen T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. J Psychosom Res 2002;52:69–77.
   PubMed Web of Science ®Google Scholar
• Woo SH, Kang DI, Ha YS, Salmasi AH, Kim JH, Lee DH, et al. Comprehensive analysis of sexual function in prostate cancer patients after robot-assisted radical prostatectomy. J Endourol 2014;28:172–7.
   PubMed Web of Science ®Google Scholar
• Berge V, Berg RE, Hoff JR, Wessel N, Diep LM, Karlsen SJ, et al. A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: quality of life outcomes after 36-month follow-up. Urology 2013;81:781–6.
   PubMed Web of Science ®Google Scholar
• Salonia A, Gallina A, Zanni G, Briganti A, Dehò F, Saccà A, et al. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;53:564–70.
   PubMed Web of Science ®Google Scholar
• Brennhovd B, Axcrona K, Fosså SD, Giercksky K-E, Vlatkovic L, Dahl AA. Robot-assisted radical prostatectomy of clinical high-risk patients with prostate cancer: a controlled study of operative and short-term postoperative events. Scand J Urol 2013;47:449–55.
   PubMed Web of Science ®Google Scholar
• Novara G, Ficarra V, D’Elia C, Secco S, De Gobbi A, Cavaleri S, et al. Preoperative criteria to select patients for bilateral nerve-sparing robotic-assisted radical prostatectomy. J Sex Med 2010;7:839–45.
   PubMed Web of Science ®Google Scholar
• Salonia A, Burnett AL, Graefen M, Hatzimouratidis K, Montorsi F, Mulhall JP, et al. Prevention and management of postprostatectomy sexual dysfunctions Part 1: Choosing the right patient at the right time for the right surgery. Eur Urol 2012;62:261–72.
   PubMed Web of Science ®Google Scholar
• Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira EDJr, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med 2010;7:1598–608.
   PubMed Web of Science ®Google Scholar
• Træen B, Stigum H. Sexual problems in 18–67-year-old Norwegians. Scand J Public Health 2010;38:445–56.
   PubMed Web of Science ®Google Scholar
• Oberst K, Bradley CJ, Schenk M. Breast and prostate cancer patient’s reliability of treatment reporting. J Registry Manag 2009;36:12–15.
   PubMedGoogle Scholar